Pipeline Products List Specialty Portfolio Updated Q2 2018 Updated Q2 2018 See below list of newly approved API’s, samples are readily available for your R&D requirements: Inhalation Ophthalmic Transdermal Sublingual Defibrotide Sodium Rituximab Abciximab Deforolimus Rivastigmine Aclidinium Bromide HCl Agomelatine Alprazolam Abemaciclib Delafloxacin Lumacaftor Rivastigmine Hydrogen Tartrate Beclomethasone Dipropionate Azithromycin Amlodipine Acalabrutinib Matuzumab Rizatriptan Benzoate Besifloxacin HCl Apomorphine Eletriptan HBr Aclidinium Bromide Desmopressin Acetate Meloxicam Rocuronium Bromide Adalimumab Difluprednate Memantine Hydrochloride Rolapitant Bimatoprost Clonidine Epinephrine Aflibercept Dinoprost Tromethamine Micafungin Romidepsin Furoate Brimonidine Tartrate Dextromethorphan Ergotamine Tartrate Agomelatine Dolasetron Mesylate Mitomycin C Bromfenac Sodium Diclofenac Levocetrizine DiHCl Donepezil Hydrochloride Furoate Rotigotine Formoterol Fumarate Cyclosporine Donepezil Alectinib Dorzolamide Hydrochloride Montelukast Sodium Rucaparib Iloprost Valerate Melatonin Alemtuzumab Doxercalciferol Moxifloxacin Hydrochloride Alirocumab Doxorubicin Hydrochloride Mycophenolate Mofetil Salmeterol Xinafoate Indacaterol Maleate Difluprednate Fingolimod Meloxicam Amphotericin B Naldemedine Secukinumab Levalbuterol Dorzolamide HCl Granisetron Montelukast Sodium Anakinra Eculizumab Nalmefene Hydrochloride Mometasone Furoate HCl Imiquimod Naloxone Angiotensin II Edaravone Naloxone Sildenafil Salmeterol Xinafoate Fluocinolone Acetonide Memantine Naltrexone Anidulafungin Edoxaban Naltrexone Sildenafil Citrate Apomorphine Hydrochloride Efinaconazole Naltrexone Hydrochloride Tiotropium Bromide Latanoprost Ondansetron Argatroban Elbasvir Nelarabine Sitagliptin Phosphate Treprostinil Sodium HCl Oxybutynin Rizatriptan Aripiprazole Enasidenib Nepafenac Sofosbuvir Acetonide Moxifloxacin HCl Palonosetron Sildenafil Atezolizumab Enfuvirtide Neratinib Maleate Sugammadex Umeclidinum Bromide Nepafenac Pramipexole Sumatriptan Atomoxetine Hydrochloride Epinastine Hydrochloride Netarsudil Sumatriptan Vilanterol Trifenatate HCl Rasagiline Tadalafil Atosiban Acetate Epinephrine Nimotuzumab Sumatriptan Succinate Atracurium Bromide Eptifibatide Niraparib Tacrolimus Tacrolimus Rivastigmine Vardenafil Avelumab Ertugliflozin Nivolumab Tadalafil Timolol Maleate Rotigotine Zolmitriptan Azelastine Hydrochloride Etanercept Nusinersen Tafluprost Tafluprost Scopolamine Zolpidem Baricitinib Etelcalcetide Obeticholic Acid Tavaborole Travoprost Vareniciline Beraprost Sodium Evolocumab Obinutuzumab (Afutuzumab) Tedizolid Phosphate Besifloxacin Hydrochloride Octreotide Acetate Betrixaban Fingolimod Ofatumumab Telavancin Injectables Bevacizumab Olopatadine Hydrochloride Telotristat ethyl Bimatoprost Fluticasone Propionate Omacetaxine Mepesuccinate Abciximab Cyclosporin Glargine Bivalirudin Fondaparinux Sodium Omalizumab Tenofovir alafenamide Adalimumab Dactinomycin Raltitrexed Bortezomib Formoterol Fumarate Ondansetron Aflibercept Dalbavancin Ixabepilone Ramosetron Fosaprepitant Ondansetron Hydrochloride Terlipressin Albiglutide Deforolimus Lanreotide Rituximab Brigatinib Fulvestrant Oxybutynin Timolol Maleate Amphotericin B Desmopressin Acetate Leuprorelin Acetate Rocuronium Bromide Brimonidine Tartrate Gemifloxacin Mesylate Oxytocin Tiotropium Bromide Brivaracetam Glecaprevir Ozenoxacin Tocilizumab/ Atlizumab Anakinra Dinoprost Tromethamine Linezolid Rolapitant Bromfenac Sodium Glucarpidase Palbociclib Trastuzumab Anidulafungin Dolasetron Mesylate Liraglutide Romidepsin Budesonide Granisetron Palmitate Travoprost Argatroban Doripenem Micafungin Sirolimus Cabazitaxel Granisetron Hydrochloride Palonosetron Treprostinil Sodium Atosiban Acetate Doxercalciferol Mitomycin Tacrolimus Calcitriol Grazoprevir Pamidronic Acid Cangrelor Pancuronium Bromide Triptorelin Pamoate Atracurium Bromide Doxorubicin Moxifloxacin HCl Tedizolid Phosphate Carboprost Trometamol Idarubicin Hydrochloride Panitumumab Umeclidinum Bromide Azacitidine Enfuvirtide Mycophenolate Mofetil Telavancin Carfilzomib Iloprost Panobinostat Ustekinumab Beraprost Sodium Enoxaprin Sodium Nelarabine Temsirolimus Carmustine Imiquimod Paricalcitol Valbenazine Bevacizumab Eptifibatide Octreotide Acetate Teriparatide Caspofungin Indacaterol Maleate Pembrolizumab Valrubicin Bivalirudin Ertapenem Omacetaxine Terlipressin Cetrorelix Infliximab Pemetrexed Disodium Vardenafil Cetuximab Ipilimumab Peramivir Vardenafil Hydrochloride Bortezomib Etanercept Mepesuccinate Tigecycline Cisatracurium Besylate Isavuconazole Pertuzumab Varenicline Tartrate Cabazitaxel Exenatide Ondansetron Trastuzumab Clonidine Ivabradine Pibrentasvir Vecuronium Bromide Calcitriol Fulvestrant Paliperidone Palmitate Treprostinil Sodium Clonidine Hydrochloride Ixabepilone Pimavanserin Vedolizumab Carboprost Trometamol Fondaparinux Sodium Palonosetron Triptorelin Cobimetinib Ixekizumab Plecanatide Velpatasvir Copanlisib Lanreotide Posaconazole Venetoclax Carfilzomib Fosaprepitant Pamidronic Acid Valrubicin Crisaborole Latanoprost Pramlintide Acetate Vilanterol Trifenatate Carmustine Gemifloxacin Mesylate Pancuronium Bromide Vecuronium Bromide Cyclosporine A Lesinurad Ramosetron Voriconazole Caspofungin Glucarpidase Paricalcitol Voriconazole Daclatasvir Leuprorelin Acetate Ranibizumab Voxilaprevir Cetrorelix Granisetron Pemetrexed Disodium Dactinomycin Levocabastine Hydrochloride Rasagiline Zolmitriptan Cetuximab Icatibant Peramivir Dalbavancin Ribociclib Daratumumab Linezolid Riluzole Cisatracurium Besylate Idarubicin HCl Pertuzumab Clofarabine Insulin Posaconazole Products covered by valid patents are not offered or supplied for commercial use. Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk. Monoclonal Antibodies (MAbs) Updated Q2 2018

LGM Pharma provides the following biological compounds towards laboratory R&D purposes. We do have cGMP scale-up and manufacturing capabilities (upstream & downstream) and would be glad to discuss further in case of interest:

Adalimumab 331731-18-1 Nivolumab 946414-94-4

Aflibercept 862111-32-8 Obinutuzumab 949142-50-1 (Afutuzumab) Alemtuzumab 216503-57-0 Ofatumumab 679818-59-8 Alirocumab 1245916-14-6 Omalizumab 242138-07-4 Atezolizumab 1380723-44-3 Panitumumab 339177-26-3 Avelumab 1537032-82-8 Pembrolizumab 1374853-91-4 Bevacizumab 216974-75-3 Pertuzumab 380610-27-5 Cetuximab 205923-56-4 Ranibizumab 347396-82-1 Daratumumab 945721-28-8 Rituximab 174722-31-7 Denosumab 615258-40-7 Romosozumab 909395-70-6 Dulaglutide 923950-08-7 Secukinumab 875356-43-7 Eculizumab 219685-50-4 Tocilizumab 375823-41-9 /Atlizumab Etanercept 185243-69-0 Trastuzumab 180288-69-1 Evolocumab 1256937-27-5 Ustekinumab 815610-63-0 Infliximab 170277-31-3 Vedolizumab 943609-66-3 Ipilimumab 477202-00-9

Ixekizumab 1143503-69-8 Products covered by valid patents are not offered or supplied for commercial use. 339186-68-4 Products currently covered by valid US Matuzumab Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1). Nimotuzumab 828933-51-3 Any patent infringement and resulting /780758-10-3 liability is solely at buyer risk.

Corporate Headquarters Business Development Unit 2758 Circleport Dr. 101 Hudson St, 21st Floor, #2158 Erlanger, KY 41018, USA Jersey City, NJ 07302, USA

Marketing & Administration Office Procurement, SCM & Logistics Office 6400 Congress Ave, Suite 1400 Hamelacha Street 15, Industrial Park Har Tuv A Boca Raton, FL 33487, USA Beit Shemesh 9905515, Israel

1-800-881-8210 [email protected] www.lgmpharma.com